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Platelet Endothelial Cell Adhesion Molecule-1
(PECAM-1/CD31) and CD99 Are Critical
in Lymphatic Transmigration of Human
Dendritic Cells
Martin Torzicky1, Petra Viznerova1, Susanne Richter2, Herbert Strobl2, Clemens Scheinecker3,
Dagmar Foedinger1 and Elisabeth Riedl1
The reverse transmigration (RT) of tissue-resident dendritic cells (DCs) across lymphatic endothelia is
prerequisite for the initiation of adaptive immune responses and might be regulated in a manner similar to
diapedesis. Specifically, CD31 and CD99, which act as gatekeepers during diapedesis, might have a role in RT
of DCs. We found that human lymphatic endothelial cells (LECs) and DCs in vitro and in human skin explants
express CD31 and CD99. In human skin, CD31 was enriched along intercellular surfaces of LECs, whereas CD99
was preferentially confined to luminal surfaces as evidenced by immunoelectron microscopy. Confocal
microscopy analysis revealed that tumor necrosis factor-alpha (TNF-a) and CXCL12 acted as inducers of RT
in vitro, but only CXCL12 stimulation resulted in a significant increase in migration rate of DCs. Upon TNF-a
stimulation, CXCL12 mRNA levels transiently increased in human fibroblasts and LECs, whereas CXCL12 protein
expression levels did not significantly change. Blocking mAbs to CD31 and CD99 significantly reduced RT of
DCs across cultured human LEC monolayers and blocked CXCL12-induced migration of DCs in whole-skin
explants. In sum, this study shows that CD31 and CD99 are involved in the RT of DCs across LECs and that
similar mechanisms promote both diapedesis and RT.
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INTRODUCTION
Consequent to inflammation of the skin, dendritic cells (DCs)
in peripheral tissues migrate via lymphatic vessels to draining
lymph nodes, a process that is termed as reverse transmigra-
tion (RT; Randolph et al., 1998). These events require
maturation of emigrating DCs and an orchestrated interplay
between DCs and lymphatic endothelia (Mellman and
Steinman, 2001). Recently, intercellular adhesion molecule-
1 has been identified as a regulator of tumor necrosis factor-
alpha (TNF-a)–dependent RT of human monocyte-derived
DCs (MoDCs) (Johnson et al., 2006; Podgrabinska et al.,
2009). Apart from cytokine-dependent and CAM-dependent
mechanisms, various chemokines have been shown to be
crucial during early and late phases of skin DC migration
(reviewed in Foerster et al., 2008). Upon maturation, DCs
upregulate CXCR4, a G-protein–coupled receptor (Zoeteweij
et al., 1998; Tchou et al., 2001), and a role for direct
engagement of CXCR4 by its cognate ligand CXCL12 in RT of
DCs has been shown in vivo and in vitro (Kabashima et al.,
2007; Ouwehand et al., 2008). Cross-talk between chemo-
kines and CAM has been demonstrated for CD31 in CXCR4-
dependent migration of megakaryocytes (Dhanjal et al.,
2007). In human skin, CD31 is found on blood endothelial
cells and dermal lymphatic endothelial cells (LECs) (Sauter
et al., 1998), suggesting a possible role for CD31 in lymphatic
transmigration of DCs. In fact, diapedesis of leukocytes has
shown to be regulated by CD31 and by CD99, a ubiquitous
32-kDa integral transmembrane protein (Aubrit et al., 1989;
Schenkel et al., 2002; Mamdouh et al., 2009).
In this study, we investigated the RT of DCs across human
LECs and found that this process is dependent on CD31- and
CD99-mediated interactions between LECs and DCs.
RESULTS
HTERT-LECs resemble primary LECs (pLECs) and express
CD31 and CD99
FACS analysis of pLECs and immortalized human LECs
(hTERT-LECs) demonstrates that virtually all cells express
the specific LEC marker molecule podoplanin, and the
adhesion molecules CD31 and CD99 (Figure 1a). Confocal
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microscopy images of confluent hTERT-LEC monolayers
reveal a cobblestone-like morphology, formation of cell
junctions, and a distinct distribution of CD31, CD99, and
podoplanin (Figure 1b). Analysis of Z-stacks of confocal
microscopy images of confluent monolayers of hTERT-LECs
and pLECs suggests a basolateral location of CD31, whereas
expression of CD99 and podoplanin seems to be more
pronounced at the luminal side of the cell surfaces (Figure
1b). In ultrathin sections of human skin, ECs of lymphatic
capillaries can be identified based on their morphological
features (Sauter et al., 1998). Immunoelectron microscopy of
LECs reveals that CD31 labeling occurs preferentially at
abluminal cell surfaces, whereas CD99 labeling is found
mainly on luminal LEC surfaces (Figure 1c and Supplemen-
tary Table S1 online).
Mature human MoDCs migrate along a CXCL12 gradient
in a chemotaxis assay and across LEC monolayers in an
in vitro assay of RT
The migratory capacity of MoDCs was analyzed in a
chemotaxis assay using collagen-coated transwells.
Figure 2a shows that only a low percentage of immature
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Figure 1. Phenotypic analysis of primary lymphatic endothelial cells (pLECs) and immortalized human LECs (hTERT-LECs). (a) FACS analysis of pLECs (upper
panel) and hTERT-LECs (lower panel) for expression of podoplanin, CD31, and CD99 (closed histograms) compared with isotype-matched controls (open
histograms). (b) Laser scanning microscope analysis of hTERT-LEC monolayers for expression and distribution of podoplanin (FITC), CD31 (tetramethyl
rhodamine isothiocyanate, TRITC), and CD99 (TRITC) in horizontal (upper panel) and vertical (lower panel) stack sections. Representative experiments are
shown (n¼ 3). Scale bar¼ 50mm. (c) Immunoelectron microscopy images from ultrathin sections of human skin and immunogold labeling (arrowheads) of
CD31 (left panel) and CD99 (right panel) on luminal (luminal) and intercellular surfaces (*) of LECs. Representative images of at least 30 cell profiles
(n¼2) are shown. Insets show  2 original magnifications. Bar¼ 500 nm.
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MoDCs migrate along a CXCL12 gradient. This number
significantly increases if MoDCs undergo TNF-a–induced
maturation. Furthermore, a similar proportion of mature
MoDCs migrate in response to CXCL12 and CCL21 (Figure
2a). This is in line with an upregulated expression of CXCR4
(73.33±15.07%) and CCR7 (64.24±4.75%) on mature
MoDCs (Supplementary Figure S1 online).
To study RT across LECs in vitro, confluent monolayers of
hTERT-LECs or pLECs were established on the undersurface of
collagen-coated transwells as described in Materials and
Methods. Before the start of migration, transwells were
placed into culture plates to initiate RT of DCs in a
basolateral-to-luminal direction. Spontaneous RT rate
accounts for less than 1% of total MoDCs (Figure 2b). TNF-
a–induced activation of LEC monolayers increases RT by
2-fold (Figure 2b). Addition of CXCL12 leads to a 68-fold
increase in migration rate (Figure 2b). These results point
to an interplay between TNF-a– and CXCL12-dependent
mechanisms possibly via chemokine-dependent regulation
of CD31 and CD99 on LECs and DCs, respectively.
Blocking mAbs against CD31 and CD99 inhibits RT
of human MoDCs
Figure 3a shows that preincubation of LEC monolayers with
blocking mAbs directed against CD31 and CD99, alone or in
combination, reduces MoDC migration rate by 50% and
66%, respectively. Similarly, blocking of CD31 and CD99 on
MoDCs results in a reduction of RT to 45% (CD31), 45%
(CD99), and 54% (CD31 and CD99). Comparable results are
obtained when pLEC monolayers are used (Figure 3b). These
data show that blocking of CD31 and CD99 reduces RT
significantly whether LECs or DCs are incubated with the
respective blocking mAbs.
Time kinetics analysis of mRNA and protein expression of
CXCL12 in human fibroblasts, hTERT-LECs, and pLECs
In line with previous studies (Ouwehand et al., 2008), we
found that human fibroblasts express abundant CXCL12
mRNA (Figure 4a). HTERT-LECs express slightly lower, but
still ample amounts of CXCL12 mRNA, and respond to TNF-a
stimulation with a transient increase in relative CXCL12
mRNA (Figure 4a). Human fibroblasts and hTERT-LECs
express comparable but overall very low amounts of CCL21
mRNA (data not shown), indicating that in the dermal
microenvironment CXCL12 might be more critical than
CCL21. CXCL12 protein can be readily detected in human
fibroblasts and in hTERT-LECs of various passages (Figure 4b).
In addition, pLECs contain ample amounts of CXCL12
protein. Quantification of time kinetic experiments shows
no significant changes in CXCL12-relative protein levels in
both h-TERT-LECs and pLECs in response to TNF-a stimula-
tion (Figure 4c).
Skin lymphatic endothelia express the adhesion molecules
CD31 and CD99 and produce CXCL12
Lymphatic and blood capillaries in normal human skin
express CD31 and CD99, whereas podoplanin expression is
restricted to typical thin-walled lymphatics of the dermis
(Figure 5). Interestingly, CXCL12 protein is readily detectable
in LECs and blood endothelial cells, but not in dermal
fibroblasts (Figure 5, bottom panel). In line with the
immunoelectron microscopy data, analysis of lymphatic
capillaries in ultrathin frozen skin sections by laser scanning
microscope shows that whereas podoplanin preferentially
localizes to the luminal side of the lymphatic vessel, CD31 is
found both on the luminal and the abluminal surfaces, and
CD99 expression is more pronounced on the luminal side of
the cell surface (Supplementary Figure S2 and Table S1
online).
CXCL12 is required for RT of MoDCs across LEC monolayers
in vitro and for RT of skin-resident DCs in human skin explants
Not all MoDCs successfully migrate across hTERT-LEC
monolayers and reach the lower compartment of the
transwells in our in vitro model of RT. Around 50% of
MoDCs remain within the hTERT-LEC monolayer, and in the
absence of a migratory stimulus less than one-third of HLA-
DRþ cells (27.8±3.0%) are found on the luminal side of LEC
monolayers. TNF-a and CXCL12, alone and in combination,
significantly increase the proportion of HLA-DRþ DCs ‘‘in
migration’’ by 2.0-fold (95% confidence interval: 1.3–2.6),
1.9-fold (95% confidence interval: 1.5–2.3), and 2.2-fold
(95% confidence interval: 2.0–2.3), respectively (Figure 6a).
25
Control
CXCL12
iMoDCs mMoDCs
*
*
* *
*
20
15
10
5
0
30
25
20
15
10
5
0
Control CXCL12
CXCL12Chemokine
6
Ab
so
lu
te
 n
um
be
r o
f
H
LA
–D
R
 
+
ce
lls
 (E
x1
04
)
5
4
3
2
1
0
Monolayer
CXCL12
TNF-αTNF-α
CCL21
%
 O
f m
ig
ra
te
d 
M
oD
Cs
%
 O
f m
ig
ra
te
d 
m
M
oD
Cs
Figure 2. Chemotaxis and reverse transmigration (RT) of monocyte-derived
dendritic cells (MoDCs) in response to tumor necrosis factor-alpha (TNF-a)
and CXCL12. (a) Comparative quantitative analysis of immature MoDCs vs.
mature MoDCs (mMoDCs) in a chemotaxis assay along a CXCL12 gradient
(upper panel) and chemotaxis of mMoDCs in response to CXCL12 vs. CCL21
(lower panel; *Po0.05; mean±SEM; n¼ 4). (b) Analysis of RT of MoDCs
across hTERT monolayers in the presence of TNF-a and/or CXCL12. Bars
represent absolute numbers of HLA-DRþ cells that have fulfilled RT across
immortalized human lymphatic endothelial cells (hTERT-LECs) monolayers
(*Po0.05; mean±SEM, n¼3).
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Similarly, in CXCL12-supplemented cultures of human
whole-skin explants, a portion of dermal HLA-DRþDCs is
found in association with lymphatic capillaries (Figure 6b).
Blocking of CD31 and CD99 by mAbs reduces CXCL12-
dependent RT of DCs in human skin cultures, and this is
paralleled by a decrease in the number of DCs adhering to
LECs. Quantitative analysis by laser scanning microscope
shows consistently a decrease in HLA-DRþ cells in the
dermis upon addition of blocking mAbs to CD31 and CD99
compared with control Ab VIAP (Figure 6b, c). This effect is
statistically significant for anti-CD99 mAb alone and for the
combination of anti-CD99 and anti-CD31 mAb (Figure 6c),
but their effect on HLA-DRþ cell migration is not additive.
DISCUSSION
CD31 and CD99 are known to be critically involved in
transmigration of leukocytes during diapedesis out of blood
vessels to sites of inflammation. We hypothesized that the
same mechanisms might regulate RT of DCs across LEC en
route from peripheral tissues to draining lymph nodes. We
found that both molecules are involved in the RT of DCs
across lymphatic endothelia. In diapedesis, PECAM and
CD99 function by means of homotypic interactions between
leukocytes and blood endothelial cells (Muller, 2011). We
used monolayers of immortalized LECs that resemble LECs
in vivo to study RT in vitro. Human TERT-LECs express the
LEC-specific marker molecule podoplanin (Breiteneder-
Geleff et al., 1999), and the cell adhesion molecules CD31
and CD99. Recently, Mamdouh et al. (2009) showed that
both molecules, CD31 and CD99, regulate paracellular and
transcellular routes of leukocyte diapedesis in vitro, and the
authors suggested a sequential process of transcellular
diapedesis in which CD31 functions before the CD99-
dependent step, as has been shown for paracellular migration
(Schenkel et al., 2002). These findings might translate to RT of
DCs across LECs. In human skin, we found that CD31 was
enriched along cell borders, whereas CD99 was preferen-
tially confined to the luminal side of the cell surfaces. This is
in contrast to the distribution described in human umbilical
vein endothelial cells in vitro where both molecules, CD31
and CD99, locate to cell junctions (Mamdouh et al., 2009).
One explanation for the different distribution between the
different cell types could be the fact that we studied skin in
the absence of inflammatory stimuli.
In line with others, we found that on a quantitative level
TNF-a had only a moderate effect on RT of MoDCs across
LEC monolayers (Johnson et al., 2006). The migration rate of
MoDCs in response to TNF-a stimulation increased only by 2-
fold, and only in the presence of CXCL12 substantial numbers
of MoDCs completed migration across LEC monolayers.
However, TNF-a was as efficient as CXCL12 in inducing
migration of MoDCs, as evidenced by the fact that analysis of
LEC monolayers by confocal microscopy revealed under both
conditions a similar proportion of HLA-DRþ DCs within the
monolayers that were ‘‘in migration’’ (Figure 6a). Thus, TNF-
a seems to be more important for the initiation of RT, possibly
by facilitating adhesion to LECs through upregulation of
adhesion molecules, but DCs fail to successfully complete
migration in the absence of additional stimuli such as
CXCL12.
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Figure 3. Effects of blocking mAbs to CD31 and CD99 on CXCL12-mediated reverse transmigration (RT) of monocyte-derived dendritic cells (MoDCs).
(a) Total numbers of HLA-DRþ cells in the lower compartment (bars) after incubation of immortalized human LEC (hTERT-LEC) monolayers (upper left graph)
or MoDCs (right graph) with the indicated blocking mAb or an isotype control mAb (VIAP) before RT. *Po0.05; mean±SEM, n¼ 3. (b) Shows the same
experiments using primary LEC (pLEC) monolayers (*Po0.05; mean±SEM, n¼ 6). Control, medium alone; CXCL12, without Ab; ns, no statistically
significant difference between blocking the target molecules on either MoDCs or hTERT-LECs.
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One possible explanation for the modest effect of TNF-a
on migration rates of DCs might be the fact that MoDCs differ
from Langerhans cells in vivo. Although MoDCs share
phenotypic and functional characteristics with Langerhans
cells in vivo, it is clear that monocyte-derived cells can serve
only as a model and as such might not mirror precisely events
in vivo.
Recent studies suggest an interdigitating signaling network
between CAM and chemokines. It has been shown that
CXCR4-dependent migration of megakaryocytes within the
vasculature of the bone marrow is regulated by CD31
(Dhanjal et al., 2007), and that migration of hepatic stellate
cells in response to CXCL12 is defective in CD31 knockout
mice (Ross et al., 2008). Similarly, CD99 has been shown to
be involved in CXCR4-dependent transendothelial migration
of hepatic stellate cells (Imbert et al., 2006). In our study,
CXCL12 functioned as a potent migratory stimulus for RT of
MoDCs. This effect was further enhanced upon activation of
hTERT-LEC monolayers by TNF-a and could be only partially
blocked by the combined addition of blocking mAbs to
CXCR4 and CXCL12 (data not shown). Blocking of CD31 and
CD99 by mAbs reduced CXCL12-dependent RT by almost
50%. These inhibitory effects were comparable and inde-
pendent of the target cell: CXCL12-dependent RT was
efficiently blocked whether MoDC or hTERT-LEC monolayers
were preincubated with the blocking mAb. In experiments
with full-thickness skin explants, CXCL12-induced RT was
blocked by mAbs against CD31 or CD99. This was paralleled
by an increase in the number of epidermal Langerhans cells
(data not shown), reflecting their inability to migrate toward
the CXCL12 gradient. Although an effect of TNF-a has not
been formally investigated in the skin explant experiments,
one can assume that endogenous TNF-a contributed to the RT
of DCs observed in skin explants.
We could identify hTERT-LECs as a source of CXCL12, and
found a transient increase in mRNA levels upon stimulation
with TNF-a. In line with recent studies (Avniel et al., 2006;
Ouwehand et al., 2008), we could detect CXCL12 protein in
both primary human LECs and hTERT-LECs. Time kinetic
analysis showed no significant change of CXCL12 protein
expression in response to TNF-a stimulation. Interestingly, in
human skin, in situ CXCL12 protein expression was found to
be restricted to ECs, thus underlining its importance in RT.
In conclusion, we report that CD31 and CD99, in analogy
to their role in diapedesis, are involved in RT of DCs across
lymphatic endothelia. Blocking mAbs to CD31 and CD99
interfered with CXCL12-dependent RT in vitro and in situ. We
also showed in an in vitro model that TNF-a functions as an
inducer of RT but that CXCL12 is required for DCs to
complete migration. Collectively, these data elucidate an
early step in the complex process of DC trafficking from skin
to draining lymph nodes.
MATERIALS AND METHODS
Antibodies
MAb/fluorochrome conjugates directed against the following anti-
gens were used in this study: CD14 (MfP9), HLA-DR (L243), CD80
(L307.4), CD86 (2331), and CD1a (HI149), all were obtained from
BD Biosciences (San Diego, CA); CD31 (5.6E) was obtained from
Immunotech (Marseille, France); CXCR4 (44716), CCR7 (150503)
CD31 (9G11), and CXCL12 (79014) were obtained from R&D
(Minneapolis, MN); and CXCL12 (FL-93) was obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). Blocking anti-CD99 mAb
(clone 3B2/TA8, IgG1; Waclavicek et al., 1998) and a non-binding
control mAb (clone VIAP, IgG1) (Majdic et al., 1994) were kindly
provided by Dr Otto Majdic (Medical University of Vienna, Vienna,
Austria). Blocking anti-CD31 mAb (clone CLB-HEC/75, IgG1) was
purchased from PeliCluster (Amsterdam, The Netherlands), poly-
clonal rabbit anti-podoplanin Ab was purchased from Acris (Herford,
Germany), and mouse anti-podoplanin mAb (D2-40) was purchased
from Cell Marque (Rocklin, CA). Anti-mouse Alexa 555, Alexa 488,
anti-rabbit Alexa 488 (Invitrogen, Eugene, OR), and anti-mouse
tetramethyl rhodamine isothiocyanate-conjugated Ab (Jackson Immuno
Research Laboratories, West Grove, PA) served as second-step Abs.
Primary cells and cell lines
Monocytes and MoDCs. The ethics committee of the Medical
University of Vienna approved the study, and written consent was
obtained from all participants; this work was conducted according to
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Figure 4. Analysis of CXCL12 mRNA and protein expression in human
fibroblasts, immortalized human lymphatic endothelial cells (hTERT-LECs),
and primary LECs (pLECs). (a) Semiquantitative real-time PCR analysis of
CXCL12 mRNA expression in hTERT-LECs compared with human fibroblasts
(left), and time kinetics analysis of CXCL12 mRNA expression (right) after
stimulation with tumor necrosis factor-alpha (TNF-a) for 4 and 24 hours
compared with non-stimulated hTERT-LEC (0 hours; mean±SEM; n¼ 3).
(b) Western blot analysis of CXCL12 protein expression in pLECs and
hTERT-LECs before (0 hours) and after stimulation with TNF-a for 4 and 24
hours. Mouse RAW246.7 and human fibroblasts served as positive controls.
One representative experiment is shown. (c) Bar diagram of CXCL12
expression. Western blot bands were quantified and the ratio of
CXCL12 to actin was calculated. Bars show mean±SEM of three
independent donors.
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the Declaration of Helsinki Principles. Monocytes were isolated
from peripheral blood mononuclear cells of healthy volunteers by
high-gradient magnetic sorting using the MACS technique (Miltenyi
Biotec GmbH, Bergisch Gladbach, Germany) according to the
manufacturer’s instructions. Briefly, peripheral blood mononuclear
cells were incubated with anti-CD14 micro-beads (Miltenyi Biotec),
washed, and passed through LS Columns (Miltenyi Biotec). FACS
analysis confirmed that more than 95% of cells expressed CD14.
CD14þ cells were cultured (5 105 cells per ml) in RPMI1640
containing 10% fetal calf serum (Invitrogen), and were supplemen-
ted with 50 ngml1 granulocyte-macrophage colony-stimulating
factor (Strathman Biotech GmbH, Hannover, Germany), 50 ngml1
IL-4, and 5 ngml1 transforming growth factor-b (both from R&D) in
24-well cell culture plates (Costar, Corning, NY) at 371C in a
humidified CO2-containing atmosphere. Cells were collected on day
5. For induction of maturation, cells were cultured (1 106 cells per
ml) in RPMI1640/10% fetal calf serum and supplemented with
50 ngml1 TNF-a (Strathman) for 48 hours.
H&E IgG
CD31
CD99
Podo
CXCL12
Figure 5. Podoplanin (Podo)þ lymphatic endothelial cells (LECs) in human skin express CD31 and CD99, and produce CXCL12. Immunohistochemistry
analysis of paraffin-embedded sections of human skin stained with Abs to CD31, CD99, podo, and CXCL12, respectively. Hematoxylin and eosin (H&E)
staining, and negative control (isotype control Ab) are shown in the top panel. Bar¼50 mm. One representative experiment is shown.
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Primary human LECs and hTERT-LECs
PLECs isolated from foreskin were purchased from PromoCell
(Heidelberg, Germany). Human skin LECs, immortalized by retro-
viral transduction with human telomerase gene (hTERT-LEC; Nisato
et al., 2004), were graciously provided from Dr Marion Groeger
(Medical University of Vienna). Primary LECs and hTERT-LECs were
cultured in endothelial cell growth medium MV (ECGM, PromoCell),
supplemented with 10% fetal calf serum (Invitrogen), 50Uml1
penicillin, and 50mgml1 streptomycin (Invitrogen). When indi-
cated, TNF-a (10 ngml1) was added to cell cultures.
Human fibroblasts and RAW246.7 cells
Primary human fibroblasts were isolated from human foreskin
samples and were cultured in a DMEM (Invitrogen)/10% fetal calf
serum. The mouse macrophage cell line RAW 246.7 was used as a
positive control in western blot assays.
Immunofluorescence staining of LEC monolayers
Transwell inserts containing LEC monolayers were gently washed in
Dulbecco’s phosphate-buffered saline, fixed in 2% paraformaldehyde
(Neuber, Vienna, Austria), and subjected to immunofluorescence
staining. Immunofluorescence staining of hTERT-LEC monolayers
was performed with unconjugated primary mAbs, followed by FITC-
and tetramethyl rhodamine isothiocyanate-conjugated second-
step goat anti-mouse IgG. Specimens were washed between steps
using Dulbecco’s phosphate-buffered saline/1% BSA (Sigma Aldrich,
St Louis, MO), mounted with Fluoprep (BioMe´rieux, Marcy l‘Etoile,
France), and analyzed by confocal laser scan microscopy.
Immunoelectron microscopy
Postembedding immunogold labeling was performed on Lowicryl
K4M sections. Specimens of normal human skin were fixed in
paraformaldehyde-lysine-periodate fixative for 1 hour, washed,
dehydrated in ethanol, and embedded in Lowicryl K4M resin
(Polysciences, Warrington, PA) by low-temperature method
(Armbruster et al., 1982). Ultrathin sections were prepared and
mounted on mesh grids. Sections were quenched in phosphate-
buffered saline containing 1% BSA (Sigma Aldrich) for 10 minutes,
followed by incubation with mAb to CD31, CD99, or an irrelevant
mouse IgG for 2 hours at 201C. After washing in phosphate-buffered
saline, the sections were incubated for 60 minutes in goat anti-
mouse gold conjugate (5 nm, Amersham, Piscataway, NJ), diluted to
1:10, at 201C. Finally, specimens were washed, counterstained, and
examined using a JEOL 1010 transmission electron microscope (Jeol,
Peabody, MA).
Immunohistochemistry of human skin sections
Deparaffinized sections of normal human skin were incubated with
primary Ab for 25 minutes at 201C, followed by biotinylated second-
step Ab and a streptavidin–peroxidase complex (Vector Laboratories,
Burlingame, CA), according to the manufacturer’s instructions.
Peroxidase reaction product was visualized by 0.01% 3-amino-9-
ethyl-carbazol (Dako, Glostrup, Denmark) in 50mMl1 acetate
buffer (pH 5, 0.015% H2O2, 5% dimethylformamide). Sections were
counterstained with hematoxylin (Dako) and mounted in Aqua-
mount (Merck, Darmstadt, Germany). For hematoxylin and hema-
toxylin/eosin staining of paraffin sections, an automated staining
machine (Autostainer Link 48, Dako) was used. Images were taken
with a BX41-TF5 binocular light microscope (Olympus, Tokyo,
Japan) using achromats  10,  20,  40, and  60 objectives, and
a DP72 12.8 megapixel cooled digital color camera (Olympus).
Chemotaxis assay
MoDCs (2 105 cells per ml) were collected, resuspended in
migration medium (RPMI 1640/2mM L-glutamine/1% BSA), and
added to the upper chamber of bovine collagen type I (Cohesion
Technologies, Palo Alto, CA)–coated transwells (pore size: 5 mm;
Costar). The lower chamber contained 600ml migration medium
supplemented with CXCL12 (100 ngml1) or CCL21 (200 ngml1),
respectively, (PeproTech, Rocky Hill, NJ). Migration was performed
at 371C in a humidified CO2-containing atmosphere for 8 hours.
LEC monolayers and RT assay
LEC monolayers (2.5 105 cells) were established on the undersur-
face of bovine collagen type I–coated transwells (Costar). Cells were
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Figure 6. Blocking mAbs against CD99 and CD31 impair reverse
transmigration (RT) of monocyte-derived dendritic cells (MoDCs) in vitro
and in situ. (a) Immortalized human lymphatic endothelial cells (hTERT-LECs)
monolayers were analyzed by confocal microscopy after completion of RT.
Bars show percentages of HLA-DRþ MoDCs on the luminal side of hTERT-
LEC monolayers with or without stimulation with tumor necrosis factor-alpha
(TNF-a), CXCL12s, or a combination of both (*Po0.05; mean±SEM, n¼ 3).
(b) Horizontal stack sections of human skin explants incubated with a
nonbinding control Ab VIAP (left) or blocking anti-CD99 mAb (TA8) (right)
and stained for CD31 (tetramethyl rhodamine isothiocyanate, TRITC) and
HLA-DR (FITC) expression. Bar¼ 50mm. (c) Quantitative laser scanning
microscope analysis of percentages of HLA-DRþ DCs in the dermis
(gray bars) in the absence (control; CXCL12) or in the presence of blocking
mAb (CD31, CD99) or a nonbinding control Ab (VIAP; *Po0.05;
mean±SEM, n¼ 3).
www.jidonline.org 1155
M Torzicky et al.
CD31 and CD99 in Migration of Dendritic Cells
allowed to adhere for 8 hours in 100 ml ECGM. When indicated,
TNF-a (10 ngml1) was added for the last 4 hours. Afterward,
the transwells were turned, placed back into the wells, and DCs
(2 105 per ml) were added to the upper transwell chamber.
Migration was performed in migration medium supplemented with
chemokines when indicated for 8 hours at 371C in a humidified
CO2-containing atmosphere. HLA-DR
þ cells in the lower chamber
were evaluated and designated as ‘‘DCs post migration’’ Numbers
of HLA-DRþ cells within the inserts were assessed by confocal
microscopy and designated as ‘‘DCs in adhesion’’ or ‘‘DCs in
migration’’ according to their position in relation to the monolayer.
For experiments using blocking mAb, MoDC or hTERT-LEC mono-
layers were preincubated with the respective mAb for 30 minutes
before RT.
Human skin explants
Healthy human skin was obtained directly after surgery. Full-
thickness skin samples of approximately 4mm2 were incubated with
blocking mAb (20 mgml1) for 1 hour at 371C. Subsequently,
CXCL12 (100 ngml1) was added and cultures were performed for
16 hours at 371C in a humidified CO2-containing atmosphere.
Finally, 5mm cryostat sections were cut, fixed with acetone, and
immunofluorescence staining was performed. Image analysis was
performed with scion image Alpha 4.0.3.2 (Scion Corporation,
Frederick, MD).
Real-time PCR
Total RNA was extracted from cells (1 106) using the RNeasy Mini
Kit as described by the manufacturer (Qiagen, Valencia, CA).
Contaminating DNA was removed by DNase digestion (Qiagen).
cDNA was synthesized using the Reverse Transcription System
according to the manufacturer’s instructions (Fermentas, St Leon-Rot,
Germany). The mRNA levels of CXCL12 and CCL21 in cells were
determined by real-time PCR using Platinum SYBR Green qPCR
SuperMix-UGD (Invitrogen). The cDNA was quantified by real-time
PCR for a traditional housekeeping gene glyceraldehyde 3-phos-
phate dehydrogenase. Designed primers were as follows: CXCL12,
50-AGAGCCAACGTCAAGCATCT-30 and 50-CTTTAGCTTCGGGTC
AATGC-30; CCL21, 50-GACACCATCCCCACAGAAAC-30 and 50-TCA
GTCCTCTTGCAGCCTT-30 (MWG-Biotech, Ebersberg, Germany).
Thermal cycling and quantification of fluorescence were performed
with a LightCycler Carousel-Based System (Roche Diagnostics,
Basel, Switzerland). Threshold cycle numbers (Ct) were determined
with the Sequence Detector Software (LightCycler Software 3.5.28,
Roche Diagnostics) and transformed by applying the DDCt method
using glyceraldehyde 3-phosphate dehydrogenase as the calibration
cDNA.
Western blot analysis
For western blot analysis, cells were lysed in 1 SDS loading dye at
951C for 10 minutes. Protein was loaded onto 10% SDS-poly-
acrylamide gradient gels. The proteins were resolved by SDS-PAGE
and transferred to a polyvinyleme diflouride membrane (Immobilon-
P, Millipore, Billerica, MA). Membranes were incubated overnight at
41C with rabbit anti-CXCL12 (Santa Cruz Biotechnology) and rabbit
anti-actin (Sigma Aldrich). As second-step Ab, horseradish perox-
idase–coupled goat anti-rabbit Ab from Thermo Scientific (Pierce
Technology, Rockford, IL) was used. Detection was performed using
the chemiluminescent substrate SuperSignal WestPico or WestDura
(Pierce Technology). Blots were quantified using the ImageJ Software
(NIH Image, Bethesda, MD).
Statistical analysis
Data are given as mean and SEM, unless otherwise specified.
Comparison between groups was performed by analysis of variance.
The Least Significant Difference test was used for post-hoc
comparisons. P-values are given as two-tailed. A P-value o0.05
indicates statistical significance. Statistical calculations were per-
formed using SPSS 16.0 (SPSS, Chicago, IL).
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